NSN 6505-01-049-6735, 6505010496735
CLONAZEPAM TABLETS

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 010496735
Codification Country: United States
Item Name Code: INC 33952
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-049-6735

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-049-6735

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-049-6735

National Stock Number (NSN) 6505-01-049-6735, or NIIN 010496735, (clonazepam tablets) was assigned October 23, 1977 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 9 manufacturer part numbers associated with this NSN. 2 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 10 suppliers. Today, 9 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 9 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of May 24, 2017. There has been one contract issued for this part number, with one award given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP17P0649. The total value of the awarded contracts has been US$ 8.32.

There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 33952. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505010496735 does not contain precious metals.

This information was last updated on Sep 01, 2024.

Technical Characteristics

III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CLONAZEPAM TABLETS USP 0.5 MG 100S BT
EXTERIOR CONTAINER QUANTITY: (EXQT) 144
INTERMEDIATE PACKAGE QUANTITY: (PKQT) 12
EXTERIOR CONTAINER CUBIC MEASURE: (EXME) 1.000 CUBIC FEET
UNIT OF ISSUE CUBE: (SUCB) 0.007 CUBIC FEET
EXTERIOR CONTAINER WEIGHT: (ECWT) 9.00 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CLONAZEPAM TABLETS USP 0.5 MG 100S BT
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 100.000 TABLETS
PRIMARY CONTAINER TYPE: (CQCT) BOTTLE
SPECIAL FEATURES: (FEAT) CLASS 4
UNIT OF ISSUE WEIGHT: (SUWT) 0.06 POUNDS